The effects of blood group types on the risk of COVID-19 infection and its clinical outcome

Background/aim: COVID-19 Coronavirus disease of 2019 is an infectious disease outbreak later on declared as a pandemic, caused by the SARS-CoV-2 severe acute respiratory syndrome coronavirus-2 . It spreads very rapidly and can result in severe acute respiratory failure. The clinical studies have shown that advanced age and chronic diseases increase the risk of infection. However, influence of the blood groups on COVID-19 infection and its outcome remains to be confirmed. The aim of this study is to investigate whether there exists a relationship between the blood groups of the patients and risk of SARS-CoV-2 infection and the clinical outcomes in COVID-19 patients. Material and method: 186 patients with PCR confirmed diagnosis of COVID-19 were included in this study. Age, sex, blood groups, comorbidities, need for intubation and intensive care unit follow up and mortalities of the patients were analyzed retrospectively. 1881 healthy individuals, who presented to the Hacettepe University Blood Bank served as the controls. Results: The most frequently detected blood group was blood group A 57% amongst the COVID-19 patients. This was followed by blood group O 24.8% . The blood group types did not affect the clinical outcomes. The blood group A was statistically significantly more frequent among those infected with COVID-19 compared to controls 57% vs. 38%, P

___

  • 1. Zhou P, Yang XL, Wang XG, Hu B, Zhang L et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579 (7798): 270-273. doi: 10.1038/s41586- 020-2012-7
  • 2. Zhou F, Yu T, Du R, Fan G, Liu Y et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395 (10229): 1054-1062. doi: 10.1016/S0140-6736(20)30566-3
  • 3. Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X et al. Human susceptibility and resistance to Norwalk virus infection. Nature Medicine 2003; 9 (5): 548-553. doi: 10.1038/ nm860
  • 4. Jing W, Zhao S, Liu J, Liu M. ABO blood groups and hepatitis B virus infection: a systematic review and meta-analysis. BMJ Open 2020; 10 (1): e034114. doi: 10.1136/bmjopen-2019-034114
  • 5. Cheng Y, Cheng G, Chui CH, Lau FY, Chan PK et al. ABO blood group and susceptibility to severe acute respiratory syndrome. The Journal of the American Medical Association 2005; 293 (12): 1450-1451. doi: 10.1001/jama.293.12.1450-c
  • 6. Cooling L. Blood groups in infection and host susceptibility. Clinical Microbiology Reviews 2015; 28 (3): 801-870. doi: 10.1128/CMR.00109-14
  • 7. Zhao J YY, Huang H, Li D, Gu D, Lu X et al. Relationship between the ABO blood group and the COVID-19 susceptibility. MedRxiv 2020. doi: 10.1101/2020.04.08.20058073
  • 8. Li J, Wang X, Chen J, Cai Y, Deng A, Yang M. Association between ABO blood groups and risk of SARS-CoV-2 pneumonia. British Journal of Haematology 2020. doi: 10.1111/ bjh.16797
  • 9. Zietz M, Tatonetti NP. Testing the association between blood type and COVID-19 infection, intubation, and death. MedRxiv 2020. doi: 10.1101/2020.04.08.20058073
  • 10. Guillon P, Clement M, Sebille V, Rivain JG, Chou CF et al. Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies. Glycobiology 2008; 18 (12): 1085-1093. doi: 10.1093/glycob/cwn093
  • 11. Wu O, Bayoumi N, Vickers MA, Clark P. ABO(H) blood groups and vascular disease: a systematic review and metaanalysis. Journal of Thrombosis and Haemostasis 2008; 6 (1): 62-69. doi: 10.1111/j.1538-7836.2007.02818.x
  • 12. Jenkins PV, O’Donnell JS. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? Transfusion 2006; 46 (10): 1836-1844. doi: 10.1111/j.1537- 2995.2006.00975.x
  • 13. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis 2020; 18 (4): 844-847. doi: 10.1111/jth.14768
  • 14. O’donnell J, Sharif K, Emery P, Bridgewood C, Mcgonagle D. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatology 2020 May 07 [online ahead of print]. doi: 10.13140/RG.2.2.19782.83521
  • 15. O’Sullivan JM, Ward S, Fogarty H, O’Donnell JS. More on “association between ABO blood groups and risk of SARSCoV-2 pneumonia”. British Journal of Haematology 2020 May 18 [online ahead of print]. doi: 10.1111/bjh.16845
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Deni̇z UZUN, Hali̇l KARA, Muhammed Fati̇h DOĞAN, Seyfullah Oktay ARSLAN

Validity and reliability of the Turkish version of the Michigan Neuropathy Screening Instrument

Süleyman Cem ADIYAMAN, Duygu AKTAR REYHANİOĞLU, Başak ÖZGEN SAYDAM, Fırat BAYRAKTAR, Bilge KARA, Onur BULUT, Murat BEKTAŞ

Changes in P1 latencies of children with normal hearing and those with cochlear implants

Emre ESKİCİOĞLU, Günay KIRKIM, Selhan GÜRKAN, Serpil MUNGAN DURANKAYA, Tahsin Oğuz BAŞOKÇU, Enis Alpin GÜNERİ

Risk indices that predict in-hospital mortality of elderly patients

Özgür ALBUZ, Dilek DÜLGER

Fatma BİLGEN, Alper URAL, Mehmet BEKERECİOĞLU

The effect of iatrogenic subclinical hyperthyroidism on anxiety, depression and quality of life in differentiated thyroid carcinoma

Cüneyd ANIL, Nazlı GÜLSOY KIRNAP, Özlem TURHAN İYİDİR, Yusuf BOZKUŞ, Şerife Mehlika IŞILDAK, Sevde Nur FIRAT, Canan DEMİR, Aslı NAR, Neslihan BAŞÇIL TÜTÜNCÜ

Relationship between helicobacter pylori infection and pityriasis versicolor: can helicobacter pylori infection be a new etiologic factor for pityriasis versicolor?

Ömer KUTLU, Zeynal DOĞAN, Hatice Meral EKŞİOĞLU, Murat KEKİLLİ

Gülçin BABAOĞLU, Banu KILIÇASLAN, Aysun Ankay YILBAŞ, Bilge ÇELEBİOĞLU

Erkan ÖLÇÜCÜOĞLU

The relationship of the immune response mediator genes’ polymorphic variants with the methotrexate efficacy in juvenile idiopathic arthritis

Liliia Sh. NAZAROVA, Denis O. KARIMOV, Ksenia V. DANILKO, Viktor A. MALIEVSKY, Akhat B. BAKIROV, Tatiana V. VIKTOROVA